Gisslinger, Heinz <br/><br/>
Therapy strategies for multiple myeloma: current status.  [electronic resource] 

 -  Wiener klinische Wochenschrift  Aug 2003 
 - 451-61 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0043-5325 
<br/><br/><label>Standard No.: </label>10.1007/BF03041028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antineoplastic Agents--therapeutic use<br/>Arsenic Trioxide<br/>Arsenicals--therapeutic use<br/>Bone Marrow Transplantation<br/>Boronic Acids--therapeutic use<br/>Bortezomib<br/>Clinical Trials as Topic<br/>Clinical Trials, Phase II as Topic<br/>Dexamethasone--administration & dosage<br/>Diphosphonates--therapeutic use<br/>Drug Therapy, Combination<br/>Erythropoietin--therapeutic use<br/>Glucocorticoids--administration & dosage<br/>Growth Inhibitors--therapeutic use<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Oxides--therapeutic use<br/>Peripheral Blood Stem Cell Transplantation<br/>Protease Inhibitors--therapeutic use<br/>Pyrazines--therapeutic use<br/>Randomized Controlled Trials as Topic<br/>Stem Cell Transplantation<br/>Thalidomide--administration & dosage<br/>Time Factors<br/>Transplantation, Autologous<br/>Transplantation, Homologous